Reversal of Pharmacologic Mydriasis in Pediatric Subjects with Ryzumvi (0.75% Phentolamine Ophthalmic Solution): A Post-Hoc Pooled Analysis from Three Randomized, Placebo-Controlled Phase 3 Trials.
- DOI
- 10.2147/opth.s563499
- Published
- 2026
- Container
- Clinical ophthalmology (Auckland, N.Z.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/opth.s563499,
title = {Reversal of Pharmacologic Mydriasis in Pediatric Subjects with Ryzumvi (0.75\% Phentolamine Ophthalmic Solution): A Post-Hoc Pooled Analysis from Three Randomized, Placebo-Controlled Phase 3 Trials.},
author = {Pepose JS and Foster S and Pearson C and Brigell M and Charizanis K},
year = {2026},
journal = {Clinical ophthalmology (Auckland, N.Z.)},
doi = {10.2147/opth.s563499},
url = {https://doi.org/10.2147/opth.s563499}
}RIS
TY - JOUR TI - Reversal of Pharmacologic Mydriasis in Pediatric Subjects with Ryzumvi (0.75% Phentolamine Ophthalmic Solution): A Post-Hoc Pooled Analysis from Three Randomized, Placebo-Controlled Phase 3 Trials. AU - Pepose JS AU - Foster S AU - Pearson C AU - Brigell M AU - Charizanis K PY - 2026 JO - Clinical ophthalmology (Auckland, N.Z.) DO - 10.2147/opth.s563499 UR - https://doi.org/10.2147/opth.s563499 ER -
APA
JS, P., S, F., C, P., M, B., & K, C. (2026). Reversal of Pharmacologic Mydriasis in Pediatric Subjects with Ryzumvi (0.75% Phentolamine Ophthalmic Solution): A Post-Hoc Pooled Analysis from Three Randomized, Placebo-Controlled Phase 3 Trials.. Clinical ophthalmology (Auckland, N.Z.). https://doi.org/10.2147/opth.s563499
Source records
- pubmed · retrieved 2026-09-25T07:59:07.788Z
- europe-pmc · retrieved 2026-09-25T07:59:07.803Z